Public Health

Scientists find durable immunity against COVID-19 variants

In a new study from Oregon Health & Science University, researchers found the blood of people infected by COVID-19 showed telltale signals of immunity...

Bark of neem tree may protect against COVID-19 variants

In a new study from the University of Colorado and elsewhere, researchers found an extract from the bark of the neem tree may help...

Two at-home COVID-19 treatments are available

This week, the FDA authorized two oral antivirals for the treatment of COVID-19 in certain patients. The first is Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged...

Scientists discover a novel vaccine method to prevent COVID-19 infection

In a new study from The University of Hong Kong, researchers found an effective vaccine regimen in preventing SARS-CoV-2 nasal infection. They found that a...

Johnson COVID-19 vaccine 85% effective against Omicron

In a new study from the South African Medical Research Council, researchers found a homologous (same vaccine) booster shot of the Johnson & Johnson...

COVID-19 can trigger self-attacking antibodies even in mild cases

In a new study from Cedars-Sinai, researchers found infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond...

Three days of this drug cuts risk for severe COVID-19

In a new study from the Baylor University Medical Center, researchers found a three-day course of remdesivir results in a lower risk for hospitalization...

People infected with Omicron less likely to get Delta infection

In a new study from South Africa, researchers found that people who have been infected with the COVID-19 Omicron variant may be less susceptible...

FDA: Know your treatment options for COVID-19

Patients today have more treatment options in the battle against coronavirus disease. The U.S. Food and Drug Administration has approved one drug treatment for COVID-19...

Omicron variant strongly resistant to current antibodies

The omicron variant of SARS-CoV-2 is spreading at an alarming rate. It could soon replace the delta variant, which at present dominates globally. However, little...